DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Lawitz E, Poordad F, Wells J. et al.
Sofosbuvir-velpatasvir-voxilaprevir with or without ribavirin in direct-acting antiviral-experienced patients with genotype 1 hepatitis C virus.
Hepatology 2017;
65 (06) 1803-1809
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.